* The research involved 39 patients with colorectal cancer, 18 with gastric cancer, and 22 healthy controls, measuring NO and FN levels through specific reactions.
* Results showed elevated NO levels in cancer patients and reduced FN levels in colorectal cancer, suggesting these molecules may influence cancer development, potentially guiding future treatment strategies.